NeuroMetrix (NASDAQ:NURO) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of NeuroMetrix (NASDAQ:NURO) in a report issued on Saturday. The brokerage set a “sell” rating on the medical device company’s stock.

NeuroMetrix Price Performance

NASDAQ:NURO opened at $4.30 on Friday. NeuroMetrix has a fifty-two week low of $2.70 and a fifty-two week high of $9.87. The stock has a market capitalization of $8.56 million, a PE ratio of -0.69 and a beta of 2.28. The business’s 50-day simple moving average is $3.99 and its 200-day simple moving average is $3.76.

NeuroMetrix (NASDAQ:NURO) last announced its earnings results on Thursday, February 22nd. The medical device company reported ($1.43) earnings per share (EPS) for the quarter. The firm had revenue of $1.32 million during the quarter. NeuroMetrix had a negative net margin of 110.64% and a negative return on equity of 31.31%.

Institutional Trading of NeuroMetrix

A hedge fund recently bought a new stake in NeuroMetrix stock. Cerity Partners LLC acquired a new position in shares of NeuroMetrix, Inc. (NASDAQ:NURO) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned about 2.80% of NeuroMetrix at the end of the most recent reporting period. Institutional investors own 19.40% of the company’s stock.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.